USANA Health Sciences, Inc. (USNA): Price and Financial Metrics

USANA Health Sciences, Inc. (USNA): $87.51

-1.89 (-2.11%)

POWR Rating

Component Grades














  • Quality is the dimension where USNA ranks best; there it ranks ahead of 99.94% of US stocks.
  • The strongest trend for USNA is in Value, which has been heading down over the past 47 weeks.
  • USNA ranks lowest in Growth; there it ranks in the 62nd percentile.

USNA Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for USNA is 3 -- better than 84.3% of US stocks.
  • Of note is the ratio of Usana Health Sciences Inc's sales and general administrative expense to its total operating expenses; just 16.73% of US stocks have a lower such ratio.
  • For USNA, its debt to operating expenses ratio is greater than that reported by just 0.43% of US equities we're observing.
  • If you're looking for stocks that are quantitatively similar to Usana Health Sciences Inc, a group of peers worth examining would be AE, GIFI, SINO, UAMY, and TDW.
  • USNA's SEC filings can be seen here. And to visit Usana Health Sciences Inc's official web site, go to

USNA Valuation Summary

  • In comparison to the median Consumer Defensive stock, USNA's EV/EBIT ratio is 51.67% lower, now standing at 8.7.
  • Over the past 243 months, USNA's price/sales ratio has gone up 1.5.
  • Over the past 243 months, USNA's price/sales ratio has gone up 1.5.

Below are key valuation metrics over time for USNA.

Stock Date P/S P/B P/E EV/EBIT
USNA 2021-09-03 1.6 4.7 14.2 8.7
USNA 2021-09-02 1.5 4.6 14.0 8.5
USNA 2021-09-01 1.6 4.7 14.1 8.5
USNA 2021-08-31 1.5 4.6 14.0 8.5
USNA 2021-08-30 1.6 4.7 14.0 8.5
USNA 2021-08-27 1.6 4.7 14.1 8.5

USNA Growth Metrics

  • Its 4 year price growth rate is now at 34.05%.
  • Its 4 year net income to common stockholders growth rate is now at 5.77%.
  • Its 2 year cash and equivalents growth rate is now at -27.08%.
USNA's revenue has moved up $199,316,000 over the prior 15 months.

The table below shows USNA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 1,253.847 155.794 138.99
2021-03-31 1,176.001 149.274 128.733
2020-12-31 1,134.644 160.401 124.664
2020-09-30 1,095.421 168.226 115.789
2020-06-30 1,057.506 169.478 109.505
2020-03-31 1,054.531 151.998 102.906

USNA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • USNA has a Quality Grade of A, ranking ahead of 99.94% of graded US stocks.
  • USNA's asset turnover comes in at 2.095 -- ranking 5th of 677 Pharmaceutical Products stocks.
  • RGLS, VTVT, and RGEN are the stocks whose asset turnover ratios are most correlated with USNA.

The table below shows USNA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-03 2.095 0.817 1.727
2021-04-03 2.032 0.812 1.699
2021-01-02 2.059 0.816 1.726
2020-09-26 2.106 0.820 1.707
2020-06-27 2.152 0.821 1.560
2020-03-28 2.124 0.822 1.401

USNA Stock Price Chart Interactive Chart >

Price chart for USNA

USNA Price/Volume Stats

Current price $87.51 52-week high $107.85
Prev. close $89.40 52-week low $72.03
Day low $86.95 Volume 65,600
Day high $89.95 Avg. volume 89,031
50-day MA $97.32 Dividend yield N/A
200-day MA $94.12 Market Cap 1.75B

USANA Health Sciences, Inc. (USNA) Company Bio

USANA Health Sciences develops and manufactures nutritional supplements, healthy foods and personal care products. The company was founded in 1992 and is based in Salt Lake City, Utah.

USNA Latest News Stream

Event/Time News Detail
Loading, please wait...

USNA Latest Social Stream

Loading social stream, please wait...

View Full USNA Social Stream

Latest USNA News From Around the Web

Below are the latest news stories about Usana Health Sciences Inc that investors may wish to consider to help them evaluate USNA as an investment opportunity.

USANA joint-support supplement earns third seal of approval

USANA, a leader in cellular nutrition, has once again been recognized with a seal of approval by renowned third-party assessor—this time for Procosa joint-support supplement. It's the third seal Procosa has earned.*

Yahoo | September 15, 2021

USANA Athletes Nick Mayhugh And Jessica Long Lead Company's Para Athletes In Gold As They Make Their Marks In History

More professional and Olympic athletes trust USANA than any other nutritional supplement in the world and for the second consecutive summer cycle, the nutritional company cheered on a group of its para athletes as they competed in Tokyo. Over the 13-day competition, USANA Athletes earned thirteen podium finishes—seven gold, three silver, and three bronze—across athletics, judo, shooting, swimming, and wheelchair fencing and tennis events. American sprinter Nick Mayhugh and swimmer Jessica Long l

Yahoo | September 8, 2021

Salt Lake Chamber- Speaking On BusinessNA Health Sciences - Salt Lake City, UT Patch

Salt Lake Chamber: Speaking On Business: USANA Health Sciences

Patch | September 4, 2021

Immune System Boosters Market May Set Massive Growth by 2026 | Alticor, USANA Health Sciences, Bayer, Vital Nutrients

Advance Market Analytics published a new research publication on Global Immune System Boosters Market Insights, to 2026 with 232 pages and enriched with self-explained Tables and charts in presentable format. []

iCrowdNewswire | September 3, 2021

10 Ways to Build Resilience for September's Self-Improvement Month

With September designated as "National Self-Improvement Month," bestselling author and global CEO offers 10 ways to build resilience.

Yahoo | August 31, 2021

Read More 'USNA' Stories Here

USNA Price Returns

1-mo -7.86%
3-mo -13.11%
6-mo -13.48%
1-year 16.63%
3-year -29.40%
5-year 28.50%
YTD 13.50%
2020 -1.85%
2019 -33.28%
2018 58.99%
2017 21.00%
2016 -4.19%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8971 seconds.